18:03 01.09.2021

Farmak automates recruitment procedure

2 min read
Farmak automates recruitment procedure

Farmak pharmaceutical company (Kyiv) was the first among Ukrainian pharmaceutical companies to implement the SAP SuccessFactors system to automate the most important and time-consuming processes in the field of personnel management, and is introducing a new module - SAP SuccessFactors Recruiting.

According to a press release from the company, the SAP SuccessFactors Recruiting module will cover and automate the entire recruiting process - from sending applications to find a person to starting a job.

In addition, the module makes it possible to analyze the work of recruiters using HR performance metrics.

"HR specialists will be able to work more efficiently with resume databases, keep records of internal and external candidates, form groups of the most relevant applicants according to the application for recruiting and save the results of interviews," the company says.

According to Viktoria Kondrashikhina, the HR director of Farmak, this approach will significantly reduce labor costs for finding specialists and accelerate the filling of vacancies.

"Actively digitalizing its business, Farmak pays great attention to the automation of HR processes. For three years now, we have been using the SAP SuccessFactors module, which has transferred to online the setting, cascading and coordination of goals, annual assessment of corporate and managerial competencies, the formation of individual development plans, and personnel reserve. Last year, we began to introduce a module that automates staff training. This will simplify and accelerate the process of acquiring new knowledge and move from paper to digital data management. And also to develop e-learning with elements of gamification, making learning more flexible and effective. Now we are introducing recruiting automation for even greater efficiency and freeing up the time of HR specialists for other strategic tasks," she said.

Farmak is the leader of the Ukrainian pharmaceutical market. The company's product portfolio includes more than 220 complex-component modern medicines. Among the main directions are endocrinological, gastroenterological, cardiological, neurological, anti-cold and other drugs.

AD
AD
AD
AD
AD